Related Experiment Video
Updated: Jul 3, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
PKMYT1 in Cancer: Beyond Cell Cycle Checkpoints to Context-Dependent Therapeutic Vulnerability
Lingxi Li1, Binfan He1, Mengmeng Hao1
1Department of General Surgery, Translational Medicine Institute, the Affiliated Chenzhou Hospital, Hengyang Medical School, University of South China, Chenzhou, China.
PKMYT1 is a promising cancer target, crucial for cancer cells managing DNA damage but not normal cells. Inhibiting PKMYT1 shows therapeutic potential, especially in specific genetic contexts like CCNE1 amplification.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- PKMYT1 exhibits tumor-selective expression and is vital for cancer cell replication stress management.
- It's dispensable in normal cells but critical for cancer cells facing DNA damage, offering a therapeutic window.
Purpose of the Study:
- To review PKMYT1's mechanistic roles in cancer.
- To evaluate its clinical landscape and potential as a therapeutic target.
- To discuss biomarker strategies for precision targeting.
Main Methods:
- Literature review and critical evaluation of existing research on PKMYT1.
- Analysis of PKMYT1's role in cell cycle regulation, signaling, metabolism, and immune evasion.
- Examination of clinical trial data and preclinical studies involving PKMYT1 inhibitors.
Main Results:
- PKMYT1 inhibition leads to synthetic lethality in CCNE1-amplified and TP53-deficient cancers.
- PKMYT1 acts as an oncoprotein, influencing signaling, metabolism, and immune evasion (cGAS-STING).
- Selective inhibitors like lunresertib are in clinical trials, often in combination therapies.
Conclusions:
- PKMYT1 is a key target for replication stress-high malignancies.
- Precision targeting based on genetic signatures (CCNE1, TP53, ER) is crucial for efficacy.
- Understanding context-dependent roles and resistance mechanisms is essential for optimizing PKMYT1-targeted therapies.
Related Concept Videos
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

